Literature DB >> 19721877

Internal regulation of neurite plasticity: A general model.

Ana Mingorance-Le Meur1.   

Abstract

The mature central nervous system has a very limited capacity to repair itself after injury or disease, often leading to lifelong disabilities. Two key questions in neurobiology are why the brain has such limited plasticity, and how we could enhance it. There has been extensive research on how external inhibitors, present in the mature central nervous system, cooperate to restrict neurite plasticity-the ability of neurons to sprout and reorganize their connections. In a recent article, we have described an unsuspected mechanism by which neurons control (and actually repress) their capacity to sprout in a cell-autonomous manner. Our discovery implies that protrusive potential is not lost in mature neurons but internally repressed. This discovery opens up new research avenues and has a strong potential from a translational standpoint. Here I review our previous results and propose a more general hypothesis on the molecular mechanisms controlling neurite plasticity.

Entities:  

Keywords:  actin dynamics; axon; calpain; plasticity; sprouting

Year:  2009        PMID: 19721877      PMCID: PMC2734034          DOI: 10.4161/cib.2.4.8309

Source DB:  PubMed          Journal:  Commun Integr Biol        ISSN: 1942-0889


  10 in total

Review 1.  A role for cAMP in regeneration of the adult mammalian CNS.

Authors:  Tim Spencer; Marie T Filbin
Journal:  J Anat       Date:  2004-01       Impact factor: 2.610

Review 2.  Cell migration: integrating signals from front to back.

Authors:  Anne J Ridley; Martin A Schwartz; Keith Burridge; Richard A Firtel; Mark H Ginsberg; Gary Borisy; J Thomas Parsons; Alan Rick Horwitz
Journal:  Science       Date:  2003-12-05       Impact factor: 47.728

Review 3.  Cytoskeletal dynamics and transport in growth cone motility and axon guidance.

Authors:  Erik W Dent; Frank B Gertler
Journal:  Neuron       Date:  2003-10-09       Impact factor: 17.173

4.  Both the establishment and the maintenance of neuronal polarity require active mechanisms: critical roles of GSK-3beta and its upstream regulators.

Authors:  Hui Jiang; Wei Guo; Xinhua Liang; Yi Rao
Journal:  Cell       Date:  2005-01-14       Impact factor: 41.582

Review 5.  Rho kinase, a promising drug target for neurological disorders.

Authors:  Bernhard K Mueller; Helmut Mack; Nicole Teusch
Journal:  Nat Rev Drug Discov       Date:  2005-05       Impact factor: 84.694

6.  RhoA-kinase and myosin II are required for the maintenance of growth cone polarity and guidance by nerve growth factor.

Authors:  Robert P Loudon; Lee D Silver; Hal F Yee; Gianluca Gallo
Journal:  J Neurobiol       Date:  2006-07

Review 7.  Glial inhibition of CNS axon regeneration.

Authors:  Glenn Yiu; Zhigang He
Journal:  Nat Rev Neurosci       Date:  2006-08       Impact factor: 34.870

8.  Neurite consolidation is an active process requiring constant repression of protrusive activity.

Authors:  Ana Mingorance-Le Meur; Timothy P O'Connor
Journal:  EMBO J       Date:  2008-12-18       Impact factor: 11.598

9.  An inactive pool of GSK-3 at the leading edge of growth cones is implicated in Semaphorin 3A signaling.

Authors:  Britta J Eickholt; Frank S Walsh; Patrick Doherty
Journal:  J Cell Biol       Date:  2002-04-15       Impact factor: 10.539

10.  PTEN couples Sema3A signalling to growth cone collapse.

Authors:  Neil H Chadborn; Aminul I Ahmed; Mark R Holt; Rabinder Prinjha; Graham A Dunn; Gareth E Jones; Britta J Eickholt
Journal:  J Cell Sci       Date:  2006-03-01       Impact factor: 5.285

  10 in total
  1 in total

1.  Automated four-dimensional long term imaging enables single cell tracking within organotypic brain slices to study neurodevelopment and degeneration.

Authors:  Jeremy W Linsley; Atmiyata Tripathi; Irina Epstein; Galina Schmunk; Elliot Mount; Matthew Campioni; Viral Oza; Mariya Barch; Ashkan Javaherian; Tomasz J Nowakowski; Siddharth Samsi; Steven Finkbeiner
Journal:  Commun Biol       Date:  2019-05-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.